Yousif Capital Management LLC Has $667,000 Holdings in Addus HomeCare Corporation (NASDAQ:ADUS)

Yousif Capital Management LLC decreased its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 2.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,740 shares of the company’s stock after selling 156 shares during the period. Yousif Capital Management LLC’s holdings in Addus HomeCare were worth $667,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in ADUS. Amundi lifted its stake in Addus HomeCare by 185.9% in the 4th quarter. Amundi now owns 9,008 shares of the company’s stock valued at $1,139,000 after acquiring an additional 5,857 shares in the last quarter. King Luther Capital Management Corp acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $4,223,000. Victory Capital Management Inc. lifted its position in shares of Addus HomeCare by 14.0% in the fourth quarter. Victory Capital Management Inc. now owns 96,832 shares of the company’s stock worth $12,138,000 after purchasing an additional 11,872 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Addus HomeCare by 9.4% during the fourth quarter. Envestnet Asset Management Inc. now owns 42,698 shares of the company’s stock worth $5,352,000 after purchasing an additional 3,659 shares during the last quarter. Finally, Proficio Capital Partners LLC acquired a new position in Addus HomeCare during the fourth quarter worth $1,933,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the business’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Down 1.2%

Addus HomeCare stock opened at $113.79 on Friday. The stock has a 50-day simple moving average of $108.91 and a 200 day simple moving average of $111.98. The stock has a market capitalization of $2.09 billion, a P/E ratio of 25.69, a PEG ratio of 1.63 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The firm’s revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.21 EPS. Analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Saturday. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Friday. Stephens reiterated an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, Macquarie restated an “outperform” rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.